Nanoliposomes in Cancer Therapy: Marketed Products and Current Clinical Trials

The drugs used for cancer treatment have many drawbacks, as they damage both tumor and healthy cells and, in addition, they tend to be poorly soluble drugs. Their transport in nanoparticles can solve these problems as these can release the drug into tumor tissues, as well as improve their solubility...

Descripción completa

Detalles Bibliográficos
Autores principales: Taléns-Visconti, Raquel, Díez-Sales, Octavio, de Julián-Ortiz, Jesus Vicente, Nácher, Amparo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030431/
https://www.ncbi.nlm.nih.gov/pubmed/35457065
http://dx.doi.org/10.3390/ijms23084249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030431/
https://www.ncbi.nlm.nih.gov/pubmed/35457065
http://dx.doi.org/10.3390/ijms23084249

Ejemplares similares